+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Multiple Sclerosis Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 1227798
  • Report
  • 248 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbvie
  • Bayer Ag
  • Biogen
  • Merck & Co., Inc.
  • Novartis International Ag
  • Pfizer
  • MORE
Multiple Sclerosis Therapeutics market worldwide is projected to grow by US$4 Billion, driven by a compounded growth of 2.6%. Beta Interferon, one of the segments analyzed and sized in this study, displays the potential to grow at over 2.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.8 Billion by the year 2025, Beta Interferon will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 2.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$151.7 Million to the region's size and clout in the next 5 to 6 years. Over US$116.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Beta Interferon will reach a market size of US$162.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 4.2% over the next couple of years and add approximately US$1.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • AbbVie, Inc.
  • Bayer AG
  • Biogen, Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbvie
  • Bayer Ag
  • Biogen
  • Merck & Co., Inc.
  • Novartis International Ag
  • Pfizer
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Multiple Sclerosis Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Multiple Sclerosis Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Multiple Sclerosis Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Multiple Sclerosis Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Beta Interferon (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Beta Interferon (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Beta Interferon (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Corticosteroids (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Corticosteroids (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Corticosteroids (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Monoclonal Antibodies (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Monoclonal Antibodies (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Monoclonal Antibodies (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Antineoplastic Agents (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Antineoplastic Agents (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Antineoplastic Agents (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Other Drug Class (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Other Drug Class (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Other Drug Class (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Oral (Therapeutics) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Oral (Therapeutics) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Oral (Therapeutics) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Injection (Therapeutics) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Injection (Therapeutics) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Injection (Therapeutics) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Multiple Sclerosis Therapeutics Market Share (in %) by Company: 2019 & 2025

TABLE 25: United States Multiple Sclerosis Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 26: Multiple Sclerosis Therapeutics Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 27: United States Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 28: United States Multiple Sclerosis Therapeutics Market Estimates and Projections in US$ Million by Therapeutics: 2018 to 2025

TABLE 29: Multiple Sclerosis Therapeutics Market in the United States by Therapeutics: A Historic Review in US$ Million for 2009-2017

TABLE 30: United States Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

CANADA

TABLE 31: Canadian Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 32: Canadian Multiple Sclerosis Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 33: Multiple Sclerosis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 34: Canadian Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Therapeutics: 2018 to 2025

TABLE 35: Canadian Multiple Sclerosis Therapeutics Historic Market Review by Therapeutics in US$ Million: 2009-2017

TABLE 36: Multiple Sclerosis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Therapeutics for 2009, 2019, and 2025

JAPAN

TABLE 37: Japanese Market for Multiple Sclerosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 38: Multiple Sclerosis Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 39: Japanese Multiple Sclerosis Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 40: Japanese Market for Multiple Sclerosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapeutics for the Period 2018-2025

TABLE 41: Multiple Sclerosis Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Therapeutics for the Period 2009-2017

TABLE 42: Japanese Multiple Sclerosis Therapeutics Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025

CHINA

TABLE 43: Chinese Multiple Sclerosis Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 44: Multiple Sclerosis Therapeutics Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017

TABLE 45: Chinese Multiple Sclerosis Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 46: Chinese Multiple Sclerosis Therapeutics Market Growth Prospects in US$ Million by Therapeutics for the Period 2018-2025

TABLE 47: Multiple Sclerosis Therapeutics Historic Market Analysis in China in US$ Million by Therapeutics: 2009-2017

TABLE 48: Chinese Multiple Sclerosis Therapeutics Market by Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Multiple Sclerosis Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 49: European Multiple Sclerosis Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 50: Multiple Sclerosis Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 51: European Multiple Sclerosis Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 52: European Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 53: Multiple Sclerosis Therapeutics Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 54: European Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 55: European Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Therapeutics: 2018-2025

TABLE 56: Multiple Sclerosis Therapeutics Market in Europe in US$ Million by Therapeutics: A Historic Review for the Period 2009-2017

TABLE 57: European Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

FRANCE

TABLE 58: Multiple Sclerosis Therapeutics Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 59: French Multiple Sclerosis Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 60: French Multiple Sclerosis Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 61: Multiple Sclerosis Therapeutics Market in France by Therapeutics: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: French Multiple Sclerosis Therapeutics Historic Market Scenario in US$ Million by Therapeutics: 2009-2017

TABLE 63: French Multiple Sclerosis Therapeutics Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025

GERMANY

TABLE 64: Multiple Sclerosis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 65: German Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 66: German Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 67: Multiple Sclerosis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapeutics for the Period 2018-2025

TABLE 68: German Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Therapeutics: 2009-2017

TABLE 69: German Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

ITALY

TABLE 70: Italian Multiple Sclerosis Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 71: Multiple Sclerosis Therapeutics Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017

TABLE 72: Italian Multiple Sclerosis Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 73: Italian Multiple Sclerosis Therapeutics Market Growth Prospects in US$ Million by Therapeutics for the Period 2018-2025

TABLE 74: Multiple Sclerosis Therapeutics Historic Market Analysis in Italy in US$ Million by Therapeutics: 2009-2017

TABLE 75: Italian Multiple Sclerosis Therapeutics Market by Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 76: United Kingdom Market for Multiple Sclerosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 77: Multiple Sclerosis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 78: United Kingdom Multiple Sclerosis Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 79: United Kingdom Market for Multiple Sclerosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapeutics for the Period 2018-2025

TABLE 80: Multiple Sclerosis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapeutics for the Period 2009-2017

TABLE 81: United Kingdom Multiple Sclerosis Therapeutics Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025

SPAIN

TABLE 82: Spanish Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 83: Spanish Multiple Sclerosis Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 84: Multiple Sclerosis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 85: Spanish Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Therapeutics: 2018 to 2025

TABLE 86: Spanish Multiple Sclerosis Therapeutics Historic Market Review by Therapeutics in US$ Million: 2009-2017

TABLE 87: Multiple Sclerosis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Therapeutics for 2009, 2019, and 2025

RUSSIA

TABLE 88: Russian Multiple Sclerosis Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 89: Multiple Sclerosis Therapeutics Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 90: Russian Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 91: Russian Multiple Sclerosis Therapeutics Market Estimates and Projections in US$ Million by Therapeutics: 2018 to 2025

TABLE 92: Multiple Sclerosis Therapeutics Market in Russia by Therapeutics: A Historic Review in US$ Million for 2009-2017

TABLE 93: Russian Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 94: Rest of Europe Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 95: Multiple Sclerosis Therapeutics Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 96: Rest of Europe Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 97: Rest of Europe Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Therapeutics: 2018-2025

TABLE 98: Multiple Sclerosis Therapeutics Market in Rest of Europe in US$ Million by Therapeutics: A Historic Review for the Period 2009-2017

TABLE 99: Rest of Europe Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 100: Asia-Pacific Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 101: Multiple Sclerosis Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 102: Asia-Pacific Multiple Sclerosis Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 103: Multiple Sclerosis Therapeutics Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 104: Asia-Pacific Multiple Sclerosis Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 105: Asia-Pacific Multiple Sclerosis Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 106: Multiple Sclerosis Therapeutics Market in Asia-Pacific by Therapeutics: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 107: Asia-Pacific Multiple Sclerosis Therapeutics Historic Market Scenario in US$ Million by Therapeutics: 2009-2017

TABLE 108: Asia-Pacific Multiple Sclerosis Therapeutics Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 109: Multiple Sclerosis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 110: Australian Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 111: Australian Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 112: Multiple Sclerosis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapeutics for the Period 2018-2025

TABLE 113: Australian Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Therapeutics: 2009-2017

TABLE 114: Australian Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

INDIA

TABLE 115: Indian Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 116: Indian Multiple Sclerosis Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 117: Multiple Sclerosis Therapeutics Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 118: Indian Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Therapeutics: 2018 to 2025

TABLE 119: Indian Multiple Sclerosis Therapeutics Historic Market Review by Therapeutics in US$ Million: 2009-2017

TABLE 120: Multiple Sclerosis Therapeutics Market in India: Percentage Share Breakdown of Sales by Therapeutics for 2009, 2019, and 2025

SOUTH KOREA

TABLE 121: Multiple Sclerosis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 122: South Korean Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 123: Multiple Sclerosis Therapeutics Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025

TABLE 124: Multiple Sclerosis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapeutics for the Period 2018-2025

TABLE 125: South Korean Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Therapeutics: 2009-2017

TABLE 126: Multiple Sclerosis Therapeutics Market Share Distribution in South Korea by Therapeutics: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 127: Rest of Asia-Pacific Market for Multiple Sclerosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 128: Multiple Sclerosis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 129: Rest of Asia-Pacific Multiple Sclerosis Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 130: Rest of Asia-Pacific Market for Multiple Sclerosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapeutics for the Period 2018-2025

TABLE 131: Multiple Sclerosis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapeutics for the Period 2009-2017

TABLE 132: Rest of Asia-Pacific Multiple Sclerosis Therapeutics Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 133: Latin American Multiple Sclerosis Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 134: Multiple Sclerosis Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 135: Latin American Multiple Sclerosis Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 136: Latin American Multiple Sclerosis Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 137: Multiple Sclerosis Therapeutics Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017

TABLE 138: Latin American Multiple Sclerosis Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 139: Latin American Multiple Sclerosis Therapeutics Market Growth Prospects in US$ Million by Therapeutics for the Period 2018-2025

TABLE 140: Multiple Sclerosis Therapeutics Historic Market Analysis in Latin America in US$ Million by Therapeutics: 2009-2017

TABLE 141: Latin American Multiple Sclerosis Therapeutics Market by Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 142: Argentinean Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 143: Multiple Sclerosis Therapeutics Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 144: Argentinean Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 145: Argentinean Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Therapeutics: 2018-2025

TABLE 146: Multiple Sclerosis Therapeutics Market in Argentina in US$ Million by Therapeutics: A Historic Review for the Period 2009-2017

TABLE 147: Argentinean Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

BRAZIL

TABLE 148: Multiple Sclerosis Therapeutics Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 149: Brazilian Multiple Sclerosis Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 150: Brazilian Multiple Sclerosis Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 151: Multiple Sclerosis Therapeutics Market in Brazil by Therapeutics: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 152: Brazilian Multiple Sclerosis Therapeutics Historic Market Scenario in US$ Million by Therapeutics: 2009-2017

TABLE 153: Brazilian Multiple Sclerosis Therapeutics Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025

MEXICO

TABLE 154: Multiple Sclerosis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 155: Mexican Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 156: Mexican Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 157: Multiple Sclerosis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapeutics for the Period 2018-2025

TABLE 158: Mexican Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Therapeutics: 2009-2017

TABLE 159: Mexican Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 160: Rest of Latin America Multiple Sclerosis Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 161: Multiple Sclerosis Therapeutics Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 162: Rest of Latin America Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 163: Rest of Latin America Multiple Sclerosis Therapeutics Market Estimates and Projections in US$ Million by Therapeutics: 2018 to 2025

TABLE 164: Multiple Sclerosis Therapeutics Market in Rest of Latin America by Therapeutics: A Historic Review in US$ Million for 2009-2017

TABLE 165: Rest of Latin America Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 166: The Middle East Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 167: Multiple Sclerosis Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 168: The Middle East Multiple Sclerosis Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 169: The Middle East Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 170: The Middle East Multiple Sclerosis Therapeutics Historic Market by Drug Class in US$ Million: 2009-2017

TABLE 171: Multiple Sclerosis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 172: The Middle East Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Therapeutics: 2018 to 2025

TABLE 173: The Middle East Multiple Sclerosis Therapeutics Historic Market by Therapeutics in US$ Million: 2009-2017

TABLE 174: Multiple Sclerosis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Therapeutics for 2009, 2019, and 2025

IRAN

TABLE 175: Iranian Market for Multiple Sclerosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 176: Multiple Sclerosis Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 177: Iranian Multiple Sclerosis Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 178: Iranian Market for Multiple Sclerosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapeutics for the Period 2018-2025

TABLE 179: Multiple Sclerosis Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Therapeutics for the Period 2009-2017

TABLE 180: Iranian Multiple Sclerosis Therapeutics Market Share Analysis by Therapeutics: 2009 VS 2019 VS 2025

ISRAEL

TABLE 181: Israeli Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 182: Multiple Sclerosis Therapeutics Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 183: Israeli Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 184: Israeli Multiple Sclerosis Therapeutics Market Estimates and Forecasts in US$ Million by Therapeutics: 2018-2025

TABLE 185: Multiple Sclerosis Therapeutics Market in Israel in US$ Million by Therapeutics: A Historic Review for the Period 2009-2017

TABLE 186: Israeli Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 187: Saudi Arabian Multiple Sclerosis Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 188: Multiple Sclerosis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017

TABLE 189: Saudi Arabian Multiple Sclerosis Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 190: Saudi Arabian Multiple Sclerosis Therapeutics Market Growth Prospects in US$ Million by Therapeutics for the Period 2018-2025

TABLE 191: Multiple Sclerosis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Therapeutics: 2009-2017

TABLE 192: Saudi Arabian Multiple Sclerosis Therapeutics Market by Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 193: Multiple Sclerosis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 194: United Arab Emirates Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 195: Multiple Sclerosis Therapeutics Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025

TABLE 196: Multiple Sclerosis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapeutics for the Period 2018-2025

TABLE 197: United Arab Emirates Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Therapeutics: 2009-2017

TABLE 198: Multiple Sclerosis Therapeutics Market Share Distribution in United Arab Emirates by Therapeutics: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 199: Multiple Sclerosis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 200: Rest of Middle East Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 201: Rest of Middle East Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 202: Multiple Sclerosis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapeutics for the Period 2018-2025

TABLE 203: Rest of Middle East Multiple Sclerosis Therapeutics Historic Market Analysis in US$ Million by Therapeutics: 2009-2017

TABLE 204: Rest of Middle East Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

AFRICA

TABLE 205: African Multiple Sclerosis Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 206: Multiple Sclerosis Therapeutics Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 207: African Multiple Sclerosis Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 208: African Multiple Sclerosis Therapeutics Market Estimates and Projections in US$ Million by Therapeutics: 2018 to 2025

TABLE 209: Multiple Sclerosis Therapeutics Market in Africa by Therapeutics: A Historic Review in US$ Million for 2009-2017

TABLE 210: African Multiple Sclerosis Therapeutics Market Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBVIE

BAYER AG

BIOGEN

MERCK & CO., INC.

NOVARTIS INTERNATIONAL AG

PFIZER

SANOFI

TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbvie
  • Bayer Ag
  • Biogen
  • Merck & Co., Inc.
  • Novartis International Ag
  • Pfizer
  • Sanofi
  • Teva Pharmaceutical Industries
Note: Product cover images may vary from those shown
Adroll
adroll